tailieunhanh - SURVEY OF CURRENT GUIDANCE FOR CHILD HEALTH CLINICAL TRIALS

This guideline makes recommendations on best practice in the recognition and management of meningococcal disease in children and young people up to 16 years of age. It addresses the patient journey through pre-hospital care, referral, diagnostic testing, disease management, follow-up care and rehabilitation and considers public health issues. The guideline will be of interest to healthcare professionals, parents and carers who are involved in the diagnosis and management of children and young people with suspected or confirmed meningococcal disease. The guideline is based on a systematic review of the literature (see section ), including relevant studies in adult populations | Report SURVEY OF CURRENT GUIDANCE FOR CHILD HEALTH CLINICAL TRIALS The StaR Child Health Project Standards for Research with Children . Frakking . van der Lee . Klassen M. Offringa for the StaR-Child Health Group List of The StaR Child Health project Standards for Research with Executive 1. Need for clinical trials in 2. Challenges in clinical trials in 3. Recent 4. The need for scientific 1. Search 2. Study 3. Data . Descriptives of . Contents of . Quality appraisal 1. Description of scientific 2. Description of internet 3. Contents of internet 4. Quality appraisal of internet Conclusions. 17 Appendix 1. Ethical Appendix 2 Laws and regulations in pediatric drug Appendix 3 Search strategies for bibliographic Appendix 4 Searched Appendix 5 Adapted AGREE Appendix 6 Scientific publications containing Appendix 7a Overview of included guidelines internet Appendix 7b Overview of excluded guidelines internet Appendix 8a Description of internet Appendix 8b Checklist of contents of internet Appendix 8c Quality appraisal of internet Figure 1. Selection process of the bibliographic databases literature Survey of current guidance for child health clinical trials 1 List of abbreviations AGREE tool ANHMRC BPCA CHRB CIOMS EC EMEA EU FDA FDAMA FIP GCP HCTPD ICH Appraisal of Guidelines Research and Evaluation Australian National Health and Medical Research Council Best Pharmaceuticals for Children Act Convention on Human Rights and Biomedicine Council for International Organizations of Medical .